Concepedia

Author

Raisuke Iijima

Toho UniversityORCID

Also Known As

Hideki Okayama, Hiroto Kinutani, Iijima Raisuke, R IIJIMA, R Iijima, R. Iijima, Raisuke Iijima, raisuke iijima

213

Publications

3.7K

Citations

29

H-Index

80

Concepts

All Affiliations

Toho UniversityToho University Ohashi Medical CenterDeutsches Herzzentrum der CharitéKlinikum rechts der IsarMitsui Memorial Hospital
RI

About

Raisuke Iijima is an author at Toho University specializing in medicine, cardiovascular disease, and coronary heart disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

33

1.5K

2

Public Health

14

18

628

3

Biomedical Engineering

2

2

139

4

Biostatistics

2

2

34

5

Health Sciences

1

1

23

Raisuke Iijima

×

61

Publications

3.2K

Citations

29

H-Index

YearCitations

Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention

Adnan Kastrati, Franz‐Josef Neumann, Julinda Mehilli,

New England Journal of Medicine

2008

349

Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease

Julinda Mehilli, Adnan Kastrati, Robert A. Byrne,

Journal of the American College of Cardiology

2009

199

Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis

Julinda Mehilli, Robert A. Byrne, Aleksandra Wieczorek,

European Heart Journal

2008

194

Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer

Robert A. Byrne, Raisuke Iijima, Julinda Mehilli,

JACC: Cardiovascular Interventions

2009

173

A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents

Robert A. Byrne, Julinda Mehilli, Raisuke Iijima,

European Heart Journal

2008

139

Carotid artery intima-media thickness and plaque score can predict the SYNTAX score

Nobutaka Ikeda, Norihiro Kogame, Raisuke Iijima,

European Heart Journal

2011

117

Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes

Tom Adriaenssens, Robert A. Byrne, Alban Dibra,

European Heart Journal

2008

115

Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation

Masato Nakamura, Raisuke Iijima, Junya Ako,

JACC: Cardiovascular Interventions

2017

110

Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era

Raisuke Iijima, Gjin Ndrepepa, Julinda Mehilli,

American Heart Journal

2007

101

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study

Robert A. Byrne, S. Schulz, Julinda Mehilli,

American Heart Journal

2009

95

Page 1